456 related articles for article (PubMed ID: 27915472)
21. The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome.
Nickel JC; Ehrlich GD; Krol JE; Ahmed A; Sen B; Bhat A; Mell JC; Doiron RC; Kelly KL; Earl JP
BJU Int; 2022 Jan; 129(1):104-112. PubMed ID: 34143561
[TBL] [Abstract][Full Text] [Related]
22. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome.
Mohammad A; Laboulaye MA; Shenhar C; Dobberfuhl AD
Nat Rev Urol; 2024 Feb; ():. PubMed ID: 38326514
[TBL] [Abstract][Full Text] [Related]
24. Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.
Akiyama Y; Luo Y; Hanno PM; Maeda D; Homma Y
Int J Urol; 2020 Jun; 27(6):491-503. PubMed ID: 32246572
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an
Kuret T; Peskar D; Kreft ME; Erman A; Veranič P
Front Immunol; 2022; 13():960667. PubMed ID: 36045687
[TBL] [Abstract][Full Text] [Related]
26. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome.
Shie JH; Kuo HC
BJU Int; 2011 Jul; 108(2 Pt 2):E136-41. PubMed ID: 21166752
[TBL] [Abstract][Full Text] [Related]
27. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
Kuo HC
Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
[TBL] [Abstract][Full Text] [Related]
28. Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis.
Tornic J; Engeler D
Curr Opin Urol; 2024 Mar; 34(2):84-88. PubMed ID: 38117118
[TBL] [Abstract][Full Text] [Related]
29. Current best practice management of interstitial cystitis/bladder pain syndrome.
Han E; Nguyen L; Sirls L; Peters K
Ther Adv Urol; 2018 Jul; 10(7):197-211. PubMed ID: 30034539
[TBL] [Abstract][Full Text] [Related]
30. Hydrodistention does not alter bladder gene expression profiles in patients with non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Xu R; Schachar J; Evans RJ; Matthews CA; Badlani G; Walker SJ
Neurourol Urodyn; 2021 Jun; 40(5):1126-1132. PubMed ID: 33942362
[TBL] [Abstract][Full Text] [Related]
31. Clinical guidelines for interstitial cystitis/bladder pain syndrome.
Homma Y; Akiyama Y; Tomoe H; Furuta A; Ueda T; Maeda D; Lin AT; Kuo HC; Lee MH; Oh SJ; Kim JC; Lee KS
Int J Urol; 2020 Jul; 27(7):578-589. PubMed ID: 32291805
[TBL] [Abstract][Full Text] [Related]
32. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
[TBL] [Abstract][Full Text] [Related]
33. Sensory Receptor, Inflammatory, and Apoptotic Protein Expression in the Bladder Urothelium of Patients with Different Subtypes of Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Birder LA; Kuo HC
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614264
[TBL] [Abstract][Full Text] [Related]
34. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
35. Update on Urinary Tract Markers in Interstitial Cystitis/Bladder Pain Syndrome.
Grigorescu B; Powers K; Lazarou G
Female Pelvic Med Reconstr Surg; 2016; 22(1):16-23. PubMed ID: 26571430
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
37. Transgenic Mice Expressing MCP-1 by the Urothelium Demonstrate Bladder Hypersensitivity, Pelvic Pain and Voiding Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Xu S; Wang X; Wang Y; Lutgendorf S; Bradley C; Schrepf A; Kreder K; O'Donnell M; Luo Y
PLoS One; 2016; 11(9):e0163829. PubMed ID: 27684718
[TBL] [Abstract][Full Text] [Related]
38. Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.
Keay SK; Zhang CO
BJU Int; 2016 Jul; 118(1):161-72. PubMed ID: 26919663
[TBL] [Abstract][Full Text] [Related]
39. Immunogenic Cell Death Associated Molecular Patterns and the Dual Role of IL17RA in Interstitial Cystitis/Bladder Pain Syndrome.
Zhang W; Liu X; Wang J; Wang X; Zhang Y
Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979355
[TBL] [Abstract][Full Text] [Related]
40. Animal models of interstitial cystitis/bladder pain syndrome.
Tay C; Grundy L
Front Physiol; 2023; 14():1232017. PubMed ID: 37731545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
